‘Best’ places to work matter of perspective

I spend a lot of time talking to INBT students about careers and companies. A question that comes up often concerns “is that a good place to work?”.

top employers logoAll employers, (companies, universities, non-profits, even government) contrary to articles in the popular press as a rule want to be “good places to work”. During the recruiting and hiring process they will all emphasize their commitment to their employees. Much of this is self-serving blather and should be taken with a grain of salt, but clearly no organization sets out be a workplace where people are dissatisfied.

In particular, employers do try to be cognizant of the needs of specialized talent such as highly trained scientists and engineers who may be critical to corporate success. None of this, of course, means that factors such as profitability, market conditions, competitive realities and goal achievement don’t matter or occasionally overwhelm other factors. It also doesn’t mean that there are no bosses or co-workers who are jerks, places where expectations are unrealistic or situations where work pressures appear too high. Science–focused companies do, for very logical reasons, recognize the importance of scientists.

There are innumerable “best places to work” surveys: in local papers, chamber of commerce type magazines, the business press and on websites. Knowledge–based industries tend to do well on these. Also, for logical reasons, there is a correlation between profitable, growing enterprises and high rankings in workplace conditions.

Science magazine conducts an annual survey of “best employers”. A link to the 2013 results for the biotech-pharma research industry is below. The top 20 read like a Who’s Who of these companies. The key ingredients appear to be innovation, treating employees with respect, social responsibility, vision and high quality of work. The survey doesn’t mention issues like salary, job security and benefits (probably because it assumes the industry is very competitive on those areas).

Here is my personal view: take it all with a grain of salt, but consider the factors mentioned. Additionally, before making a career decision, if possible get a good sense of what employees say about the company and the specific organization.

Annual Top Employers Survey


Nanotech collaboration between Johns Hopkins and Belgium had INBT roots

Johns Hopkins Medicine recently announced exciting news of a joint collaborative agreement with IMEC, a leading nano-electronics research center based in Belgium. The objective of the partnership is to advance applications of silicon nanotechnology in health care, beginning with development of a point-of-care device to enable a broad range of clinical tests to be performed outside the laboratory. This unique venture will combine Johns Hopkins clinical and research expertise with IMEC’s technical and engineering capabilities.

TIMEC clean roomhe two organizations plan to forge strategic ties with additional collaborators across the value chain in the health care and technology sectors. Development of a next generation ”lab-on-a-chip”, making diagnostic testing faster and easier for applications such as disease monitoring and management, disease surveillance, rural health care and clinical trials, will form the initial focus of the partnership. Denis Wirtz, Associate Director of INBT, will serve on the Advisory Board for the collaboration.

The roots of the new Hopkins-IMEC partnership were initiated over five years ago when Johns Hopkins Institute for NanoBioTechnology (INBT) established a collaborative relationship with IMEC. Since its inception in 2009, the INBT-IMEC partnership has blossomed into a number of collaborative projects, which enabled both graduate and undergraduate students from Hopkins to broaden their research experience with internships at IMEC’s state-of-the-art laboratories in Leuven, Belgium (with some students from IMEC also interning at Hopkins).

These projects were built around Hopkins/INBT research interests in nanobiotechnology such as controlled drug delivery, microfluidics, stem cell platforms and neural networks to mention a few. IMEC’s massive expertise in nanofabrication, darkfield and lens-free microscopy, neuro-electronics and lithography provides a huge opportunity for JHU researchers to evaluate translational pathways for basic discoveries.

Initial discussions about a broader relationship between the two institutions originated with an INBT-IMEC team exploring possible additional opportunities building on our existing partnership. A visit to Hopkins by senior IMEC management in August 2012 was organized by INBT, and laid the groundwork for subsequent next steps which included a University-wide team. We are delighted to have identified an opportunity for Hopkins to create a collaborative model to develop potentially revolutionary new techniques combining the unique advantages of silicon technology to a new generation of diagnostics and cures.

Separate from this recent collaboration, INBT has hosted students to conduct research at IMEC since 2009. Funding to support students abroad has come from INBT and the National Science Foundation International Research Experience for Students (IRES) program.

Read the official announcement from Johns Hopkins School of Medicine here.

Check out the INBT/IMEC blog.

Read about the INBT/IMEC IRES program here.

By Tom Fekete, INBT director of corporate partnerships.